Ulrika Jahn

Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression

Jahn, Ulrika; Garske-Román, Ulrike; Sandström, Mattias; Lubberink, Mark et al.

Part of EJNMMI Research, p. 45, 2023

• DOI for Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression
• Download full text (pdf) of Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression

Peptide Receptor Radionuclide Therapy in Neuroendocrine Neoplasms: Aspects of tumour characteristics, receptor recycling and peptide mass

Jahn, Ulrika

2023

• Download full text (pdf) of Peptide Receptor Radionuclide Therapy in Neuroendocrine Neoplasms: Aspects of tumour characteristics, receptor recycling and peptide mass

Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Lubberink, Mark et al.

Part of Cancers, 2021

• DOI for Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms
• Download full text (pdf) of Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Jahn, Ulrika; Ilan, Ezgi; Velikyan, Irina; Fröss-Baron, Katarzyna et al.

Part of EJNMMI Research, 2021

• DOI for Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT
• Download full text (pdf) of Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Garske-Román, Ulrike et al.

Part of Neuroendocrinology, p. 662-670, 2020

• DOI for ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression

Jahn, Ulrika; Garske-Román, Ulrike; Sandström, Mattias; Lubberink, Mark et al.

Part of EJNMMI Research, p. 45, 2023

• DOI for Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression
• Download full text (pdf) of Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression

Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Lubberink, Mark et al.

Part of Cancers, 2021

• DOI for Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms
• Download full text (pdf) of Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Jahn, Ulrika; Ilan, Ezgi; Velikyan, Irina; Fröss-Baron, Katarzyna et al.

Part of EJNMMI Research, 2021

• DOI for Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT
• Download full text (pdf) of Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Garske-Román, Ulrike et al.

Part of Neuroendocrinology, p. 662-670, 2020

• DOI for ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy; Gender Differences in Small Intestinal and Pancreatic Neuroendocrine Tumors

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Garske-Román, Ulrike et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Comparison of Ga-68-DOTATATE and Lu-177-DOTATATE kinetics in neuroendocrine tumors

Ilan, Ezgi; Lubberink, Mark; Sandström, Mattias; Jahn, Ulrika et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

Comparison of ⁶⁸Ga-DOTATATE and ¹⁷⁷Lu-DOTATATE kinetics in neuroendocrine tumors

Ilan, Ezgi; Velikyan, Irina; Sandström, Mattias; Andersson, Camilla et al.

Peptide Receptor Radionuclide Therapy in Neuroendocrine Neoplasms: Aspects of tumour characteristics, receptor recycling and peptide mass

Jahn, Ulrika

2023

• Download full text (pdf) of Peptide Receptor Radionuclide Therapy in Neuroendocrine Neoplasms: Aspects of tumour characteristics, receptor recycling and peptide mass